Development of a new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific autoantibodies

…, F Maurier, A Meyer, A Tohmé, JL Charuel… - JAMA …, 2018 - jamanetwork.com
Importance Idiopathic inflammatory myopathies are heterogeneous in their pathophysiologic
features and prognosis. The emergence of myositis-specific autoantibodies suggests that …

Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin

Y Allenbach, L Drouot, A Rigolet, JL Charuel, F Jouen… - Medicine, 2014 - journals.lww.com
Necrotizing autoimmune myopathy (NAM) is a group of acquired myopathies characterized
by prominent myofiber necrosis with little or no muscle inflammation. Recently, researchers …

High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody

…, JL Charuel, O Boyer, F Jouen, L Drouot, J Martinet… - Brain, 2016 - academic.oup.com
Cancer can occur in patients with inflammatory myopathies. This association is mainly
observed in dermatomyositis, and myositis-specific antibodies have allowed us to delineate …

Correlation of anti–signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy

…, L Drouot, F Jouen, JL Charuel… - Arthritis & …, 2011 - Wiley Online Library
Objective Anti–signal recognition particle (anti‐SRP) autoantibodies are associated with
severe acquired necrotizing myopathies. The role of these autoantibodies remains elusive, and …

[HTML][HTML] Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency

…, L Bizien, G Hancioglu, P Ghillani-Dalbin, JL Charuel… - Nature, 2023 - nature.com
Patients with autoimmune polyendocrinopathy syndrome type 1 (APS-1) caused by autosomal
recessive AIRE deficiency produce autoantibodies that neutralize type I interferons (IFNs) …

Inflammatory myopathies with anti-Ku antibodies: a prognosis dependent on associated lung disease

…, O Dubourg, T Maisonobe, P Grenier, JL Charuel… - Medicine, 2012 - journals.lww.com
Anti-Ku antibodies have been reported in a wide spectrum of autoimmune diseases, sometimes
in association with inflammatory myopathies (IM). We studied the clinical, laboratory, …

JAK inhibitors are effective in a subset of patients with juvenile dermatomyositis: a monocentric retrospective study

…, A Isapof, JP Herbeuval, V Bondet, JL Charuel… - …, 2021 - academic.oup.com
Objective To evaluate the efficacy and safety of Janus kinase inhibitors (JAKis) in JDM.
Methods We conducted a single-centre retrospective study of patients with JDM treated by JAKi …

[HTML][HTML] Dermatomyositis with or without anti-melanoma differentiation-associated gene 5 antibodies: common interferon signature but distinct NOS2 expression

…, H Levesque, A Delluc, L Drouot, JL Charuel… - The American Journal of …, 2016 - Elsevier
The anti-melanoma differentiation-associated gene 5 (MDA5) autoantibody is specifically
associated with dermatomyositis (DM). Nevertheless, anti–MDA5 + -patients experience …

[HTML][HTML] Clinical phenotypes of patients with anti-DFS70/LEDGF antibodies in a routine ANA referral cohort

M Miyara, R Albesa, JL Charuel, M El Amri… - Journal of Immunology …, 2013 - hindawi.com
Objective. To analyze the clinical value of anti-DFS70 antibodies in a cohort of patients
undergoing routine antinuclear antibodies (ANAs) testing. Methods. Sera with a dense fine …

A child with severe juvenile dermatomyositis treated with ruxolitinib

…, ML Frémond, D Duffy, GI Rice, JL Charuel… - Brain, 2018 - academic.oup.com
Sir, We read with interest the article by Ladislau et al.(2018), highlighting the key role of type
I interferon (IFN) in the pathophysiology of the muscle disease observed in dermatomyositis …